Selected article for: "locally advanced and locoregional control"

Author: Mariam, Neethu Billy Graham; Song, Yee Pei; Joseph, Nuradh; Hoskin, Peter; Reeves, Kimberley; Porta, Nuria; James, Nicholas; Choudhury, Ananya
Title: Hypofractionation: less is more?
  • Cord-id: gjm9h269
  • Document date: 2021_8_17
  • ID: gjm9h269
    Snippet: One third of patients with bladder cancer present with muscle invasive bladder cancer (MIBC) which has a poor prognosis. International guidelines for the management of MIBC recommend radical cystectomy or bladder-preserving treatment based on radical radiotherapy with a form of radiosensitisation. In the UK, both conventional fractionation with 64 Gy in 32 fractions and hypofractionation with 55 Gy in 20 fractions are standard of care options with the choice varying between centres. A meta-analy
    Document: One third of patients with bladder cancer present with muscle invasive bladder cancer (MIBC) which has a poor prognosis. International guidelines for the management of MIBC recommend radical cystectomy or bladder-preserving treatment based on radical radiotherapy with a form of radiosensitisation. In the UK, both conventional fractionation with 64 Gy in 32 fractions and hypofractionation with 55 Gy in 20 fractions are standard of care options with the choice varying between centres. A meta-analysis of individual patients with locally advanced bladder cancer from two UK multicentre phase 3 trials was published recently. This study evaluated the non-inferiority of a hypofractionated schedule compared to a conventional regime. This analysis confirmed the non-inferiority of the hypofractionated regimen, and noted superior locoregional control. We discuss the relevance of these findings to current practice while considering the radiobiology of hypofractionation, the role of systemic therapies and radiosensitisation, as well as the socioeconomic benefits.

    Search related documents:
    Co phrase search for related documents
    • adjuvant chemotherapy and locally advanced: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • adjuvant chemotherapy and locoregional control: 1
    • adjuvant chemotherapy and locoregional recurrence: 1
    • adjuvant concurrent and locally advanced: 1
    • adjuvant concurrent and locoregional control: 1
    • adjuvant concurrent and locoregional recurrence: 1
    • adjuvant setting and local control: 1, 2
    • adjuvant setting and locally advanced: 1, 2
    • local control and locoregional control: 1, 2, 3, 4, 5, 6
    • local control and locoregional control improve: 1
    • local control and locoregional recurrence: 1, 2
    • local control and long term effect: 1
    • locally advanced and locoregional control: 1, 2
    • locally advanced and locoregional recurrence: 1, 2, 3